Skip to main content

Advertisement

SpringerLink
Log in

The Role of Vitamin D in the Metabolic Homeostasis of Diabetic Bone

  • Original Paper
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Most studies across a variety of geographic locations suggest that vitamin D insufficiency is more common in individuals with type 1 diabetes (T1D) compared to the general population. In type 2 diabetes (T2D), while obesity is commonplace and lower vitamin D levels are present in obese adolescents and adults, the association between vitamin D insufficiency and T2D is less clear. Studies suggest that the relationship between T2D and vitamin D may be concurrently influenced by ethnicity, geography, BMI and age. Nonetheless, diabetic osteopathy is a significant comorbidity of both forms of diabetes and is characterized by micro-architectural changes that decrease bone quality leading to an increased risk for bone fracture in both disorders. The question remains, however, to what degree vitamin D homeostasis contributes to or exacerbates skeletal pathology in diabetes. Proposed mechanisms for vitamin D deficiency in diabetes include (1) genetic predisposition (T1D); (2) increased BMI (T2D); (3) concurrent albuminuria (T1D or T2D); or (4) exaggerated renal excretion of vitamin D metabolites or vitamin D-binding protein (T1D, T2D, animal models). The specific effects of vitamin D treatment on diabetic osteoporosis have been examined in rodents and demonstrate skeletal improvements even in the face of untreated diabetes. However, human clinical trial data examining whether vitamin D status can be directly related to or it is predictive of bone quality and fracture risk in those with diabetes are still needed. Herein, we provide a review of the literature linking vitamin D, diabetes and skeletal health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Nyman JS, Even JL, Jo CH, et al. Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone. 2011;48:733–40.

    Article  PubMed  Google Scholar 

  2. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005;289:E735–45.

    Article  CAS  PubMed  Google Scholar 

  3. Pasoto SG, Yoshihara LA, Maeda LC, et al. Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities. Rheumatol Int. 2011 [Epub ahead of print]. doi:10.1007/s00296-011-2154-x

  4. Holmberg AH, Johnell O, Nilsson PM, Nilsson JA, Berglund G, Akesson K. Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women. Osteoporos Int. 2005;16:2185–94.

    Article  PubMed  Google Scholar 

  5. Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009;154:132–4.

    Article  PubMed  Google Scholar 

  6. Frazer TE, White NH, Hough S, et al. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab. 1981;53:1154–9.

    Article  CAS  PubMed  Google Scholar 

  7. Bener A, Alsaied A, Al-Ali M, et al. Impact of lifestyle and dietary habits on hypovitaminosis D in type 1 diabetes mellitus and healthy children from Qatar, a sun-rich country. Ann Nutr Metab. 2008;53:215–22.

    Article  CAS  PubMed  Google Scholar 

  8. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010;64(3):351–5.

    Article  CAS  PubMed  Google Scholar 

  9. Littorin B, Blom P, Scholin A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49:2847–52.

    Article  CAS  PubMed  Google Scholar 

  10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.

    Article  CAS  PubMed  Google Scholar 

  11. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398–417.

    Article  PubMed  Google Scholar 

  12. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000;11:320–7.

    Article  CAS  PubMed  Google Scholar 

  13. Negri AL. Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex. Nephrology (Carlton). 2006;11:510–5.

    Article  CAS  Google Scholar 

  14. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96:507–15.

    Article  CAS  PubMed  Google Scholar 

  15. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–87.

    Article  CAS  PubMed  Google Scholar 

  16. Holick MF. Vitamin D: a D-lightful solution for health. J Investig Med. 2011;59:872–80.

    CAS  PubMed  Google Scholar 

  17. Bener A, Alsaied A, Al-Ali M, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009;46:183–9.

    Article  CAS  PubMed  Google Scholar 

  18. Janner M, Ballinari P, Mullis PE, Fluck CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly. 2010;140:w13091.

    PubMed  Google Scholar 

  19. Greer RM, Rogers MA, Bowling FG, et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Med J Aust. 2007;187:59–60.

    PubMed  Google Scholar 

  20. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab. 2011;96:142–9.

    Article  CAS  PubMed  Google Scholar 

  21. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes. 2011;60:1624–31.

    Article  CAS  PubMed  Google Scholar 

  22. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care. 2009;32:1977–9.

    Article  CAS  PubMed  Google Scholar 

  23. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics. 2009;124:e362–70.

    Article  PubMed  Google Scholar 

  24. Simmons JH, Raines M, Ness KD, et al. Metabolic control and bone health in adolescents with type 1 diabetes. Int J Pediatr Endocrinol. 2011;2011:13.

    Article  PubMed  CAS  Google Scholar 

  25. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813–8.

    Article  CAS  PubMed  Google Scholar 

  26. Reis JP, von Muhlen D, Miller ER III, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124:e371–9.

    Article  PubMed  Google Scholar 

  27. Muscogiuri G, Sorice GP, Prioletta A, et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring). 2010;18:1906–10.

    Article  CAS  Google Scholar 

  28. Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009;29:3713–20.

    CAS  PubMed  Google Scholar 

  29. Blum M, Dolnikowski G, Seyoum E, et al. Vitamin D(3) in fat tissue. Endocrine. 2008;33:90–4.

    Article  CAS  PubMed  Google Scholar 

  30. Devaraj S, Jialal G, Cook T, Siegel D, Jialal I. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm Metab Res. 2011;43:72–4.

    Article  CAS  PubMed  Google Scholar 

  31. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010;64:351–5.

    Article  CAS  PubMed  Google Scholar 

  32. Al-Daghri NM, Al-Attas OS, Al-Okail MS, et al. Severe hypovitaminosis D is widespread and more common in non-diabetics than diabetics in Saudi adults. Saudi Med J. 2010;31:775–80.

    PubMed  Google Scholar 

  33. Hidayat R, Setiati S, Soewondo P. The association between vitamin D deficiency and type 2 diabetes mellitus in elderly patients. Acta Med Indones. 2010;42:123–9.

    PubMed  Google Scholar 

  34. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65:225–36.

    Article  CAS  PubMed  Google Scholar 

  35. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.

    Article  CAS  PubMed  Google Scholar 

  36. Liu J, Tan H, Jeynes B. Serum 25OH vitamin D level, femur length, and risk of type 2 diabetes among adults. Appl Physiol Nutr Metab. 2011;36:264–70.

    Article  CAS  PubMed  Google Scholar 

  37. Grimnes G, Emaus N, Joakimsen RM, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromso Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med. 2010;27:1107–15.

    Article  CAS  PubMed  Google Scholar 

  38. Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, obesity and lifestyle study). Diabetes Care. 2011;34:1133–8.

    Article  CAS  PubMed  Google Scholar 

  39. Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19:666–71.

    Article  PubMed  Google Scholar 

  40. Michos ED. Vitamin D deficiency and the risk of incident Type 2 diabetes. Future Cardiol. 2009;5:15–8.

    Article  CAS  PubMed  Google Scholar 

  41. Mattila C, Knekt P, Mannisto S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30:2569–70.

    Article  CAS  PubMed  Google Scholar 

  42. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes. 2008;57:2619–25.

    Article  CAS  PubMed  Google Scholar 

  43. Kayaniyil S, Retnakaran R, Harris SB, et al. Prospective associations of vitamin D with β-cell function and glycemia: the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort study. Diabetes. 2011;60(11):2947–53.

    Article  CAS  PubMed  Google Scholar 

  44. Borkar VV, Devidayal, Verma S, Bhalla AK. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2010;11:345–50.

    Article  CAS  PubMed  Google Scholar 

  45. Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37:680–3.

    Article  CAS  PubMed  Google Scholar 

  46. Huynh T, Greer RM, Nyunt O, et al. The association between ketoacidosis and 25(OH)-vitamin D levels at presentation in children with type 1 diabetes mellitus. Pediatr Diabetes. 2009;10:38–43.

    Article  CAS  PubMed  Google Scholar 

  47. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27:181–8.

    Article  CAS  PubMed  Google Scholar 

  48. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab. 2005;16:261–6.

    Article  CAS  PubMed  Google Scholar 

  49. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3–1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89–90:121–5.

    Article  PubMed  CAS  Google Scholar 

  50. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28 k in human and rat pancreas. Am J Physiol. 1994;267:E356–60.

    CAS  PubMed  Google Scholar 

  51. Ng KY, Ma MT, Leung KK, Leung PS. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Rev. 2011;7:53–63.

    Article  CAS  PubMed  Google Scholar 

  52. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.

    Article  CAS  PubMed  Google Scholar 

  53. Kajikawa M, Ishida H, Fujimoto S, et al. An insulinotropic effect of vitamin D analog with increasing intracellular Ca2 + concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology. 1999;140:4706–12.

    Article  CAS  PubMed  Google Scholar 

  54. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35:11–7.

    Article  CAS  PubMed  Google Scholar 

  55. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823–5.

    Article  CAS  PubMed  Google Scholar 

  56. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119:84–90.

    Article  CAS  PubMed  Google Scholar 

  57. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17:509–11.

    CAS  PubMed  Google Scholar 

  58. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–5.

    CAS  PubMed  Google Scholar 

  59. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient—a randomised, placebo-controlled trial. Br J Nutr. 2010;103:549–55.

    Article  CAS  Google Scholar 

  60. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307–14.

    PubMed  Google Scholar 

  61. Avenell A, Cook JA, MacLennan GS, McPherson GC. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2009;38:606–9.

    Article  PubMed  Google Scholar 

  62. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract. 2010;16:600–8.

    Article  PubMed  Google Scholar 

  63. Luo C, Wong J, Brown M, Hooper M, Molyneaux L, Yue DK. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diab Vasc Dis Res. 2009;6:194–9.

    Article  CAS  PubMed  Google Scholar 

  64. Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care. 2010;33:1443–8.

    Article  CAS  PubMed  Google Scholar 

  65. Bizzarri C, Pitocco D, Napoli N, et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care. 2010;33:1962–3.

    Article  CAS  PubMed  Google Scholar 

  66. Martin RJ, McKnight AJ, Patterson CC, Sadlier DM, Maxwell AP. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Nephrol Dial Transplant. 2010;25:497–503.

    Article  CAS  PubMed  Google Scholar 

  67. Bucan K, Ivanisevic M, Zemunik T, et al. Retinopathy and nephropathy in type 1 diabetic patients–association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL-1 receptor 1 genes. Coll Antropol. 2009;33(Suppl 2):99–105.

    CAS  PubMed  Google Scholar 

  68. Ponsonby AL, Pezic A, Ellis J, et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol. 2008;168:358–65.

    Article  PubMed  Google Scholar 

  69. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352–60.

    Article  CAS  PubMed  Google Scholar 

  70. Mimbacas A, Trujillo J, Gascue C, Javiel G, Cardoso H. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res. 2007;6:534–42.

    CAS  PubMed  Google Scholar 

  71. Boraska V, Skrabic V, Zeggini E, et al. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia. J Hum Genet. 2008;53:210–4.

    Article  CAS  PubMed  Google Scholar 

  72. Shimada A, Kanazawa Y, Motohashi Y, et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun. 2008;30:207–11.

    Article  CAS  PubMed  Google Scholar 

  73. Panierakis C, Goulielmos G, Mamoulakis D, Petraki E, Papavasiliou E, Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol. 2009;133:276–81.

    Article  CAS  PubMed  Google Scholar 

  74. Fassbender WJ, Goertz B, Weismuller K, et al. VDR gene polymorphisms are overrepresented in german patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res. 2002;34:330–7.

    Article  CAS  PubMed  Google Scholar 

  75. McDermott MF, Ramachandran A, Ogunkolade BW, et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia. 1997;40:971–5.

    Article  CAS  PubMed  Google Scholar 

  76. Kahles H, Morahan G, Todd JA, Badenhoop K. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun. 2009;10(Suppl 1):S60–3.

    Article  CAS  PubMed  Google Scholar 

  77. Lemos MC, Fagulha A, Coutinho E, et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol. 2008;69:134–8.

    Article  CAS  PubMed  Google Scholar 

  78. Israni N, Goswami R, Kumar A, Rani R. Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One. 2009;4:e8023.

    Article  PubMed  CAS  Google Scholar 

  79. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes. 2007;56:2616–21.

    Article  CAS  PubMed  Google Scholar 

  80. Kocabas A, Karaguzel G, Imir N, Yavuzer U, Akcurin S. Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2010;23:1289–97.

    Article  CAS  PubMed  Google Scholar 

  81. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001;18:842–5.

    Article  CAS  PubMed  Google Scholar 

  82. Nosratabadi R, Arababadi MK, Salehabad VA, et al. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes. Int J Immunogenet. 2010;37:493–7.

    Article  CAS  PubMed  Google Scholar 

  83. Hitman GA, Mannan N, McDermott MF, et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes. 1998;47:688–90.

    Article  CAS  PubMed  Google Scholar 

  84. Dilmec F, Uzer E, Akkafa F, Kose E, van Kuilenburg AB. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J Diabetes Complications. 2010;24:186–91.

    Article  PubMed  Google Scholar 

  85. Malecki MT, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes. 2003;111:505–9.

    Article  CAS  PubMed  Google Scholar 

  86. Bid HK, Konwar R, Aggarwal CG, et al. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci. 2009;63:187–94.

    Article  PubMed  Google Scholar 

  87. Boullu-Sanchis S, Lepretre F, Hedelin G, et al. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab. 1999;25:150–6.

    CAS  PubMed  Google Scholar 

  88. Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, et al. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol. 2006;43:114–9.

    Article  CAS  PubMed  Google Scholar 

  89. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134–9.

    Article  CAS  PubMed  Google Scholar 

  90. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002;51:356–9.

    Article  CAS  PubMed  Google Scholar 

  91. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001;145:181–6.

    Article  CAS  PubMed  Google Scholar 

  92. Ma X, Jing Y, Qin W, et al. Vitamin D receptor gene polymorphism and bone mineral density in patients with type 2 diabetes mellitus. Chin Med J (Engl). 2001;114:1213–5.

    CAS  Google Scholar 

  93. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50:69–77.

    Article  PubMed  CAS  Google Scholar 

  94. Diaz VA, Mainous AG III, Carek PJ, Wessell AM, Everett CJ. The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J Am Board Fam Med. 2009;22:521–7.

    Article  PubMed  Google Scholar 

  95. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010;33:2238–43.

    Article  PubMed  Google Scholar 

  96. Thrailkill KM, Nimmo T, Bunn RC, et al. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin. Diabetes Care. 2009;32:1266–8.

    Article  CAS  PubMed  Google Scholar 

  97. Ward DT, Yau SK, Mee AP, et al. Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes. J Am Soc Nephrol. 2001;12:779–90.

    CAS  PubMed  Google Scholar 

  98. Schneider LE, Schedl HP, McCain T, Haussler MR. Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science. 1977;196:1452–4.

    Article  CAS  PubMed  Google Scholar 

  99. Verhaeghe J, Suiker AM, Van Bree R, et al. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats. Am J Physiol. 1993;265:E215–23.

    CAS  PubMed  Google Scholar 

  100. Fowlkes JL, Bunn RC, Cockrell GE, et al. Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes. Exp Diabetes Res. 2011;2011:269378.

    Article  PubMed  CAS  Google Scholar 

  101. Anderson RL, Ternes SB, Strand KA, Rowling MJ. Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab. 2010;299:E959–67.

    Article  CAS  PubMed  Google Scholar 

  102. Ishida H, Seino Y, Matsukura S, et al. Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. Metabolism. 1985;34:797–801.

    Article  CAS  PubMed  Google Scholar 

  103. Imura H, Seino Y, Ishida H. Osteopenia and circulating levels of vitamin D metabolites in diabetes mellitus. J Nutr Sci Vitaminol (Tokyo). 1985;31(Suppl):S27–32.

    Article  CAS  Google Scholar 

  104. Hampson G, Evans C, Petitt RJ, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41:1314–20.

    Article  CAS  PubMed  Google Scholar 

  105. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Lumpkin CK, Jr., Fowlkes JL. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int. 2011 [Epub ahead of print]. doi:10.1007/s00198-011-1807-7.

  106. Takeshita N, Mutoh S, Yamaguchi I. Osteopenia in genetically diabetic DB/DB mice and effects of 1alpha-hydroxyvitamin D3 on the osteopenia. Basic Research Group. Life Sci. 1995;56:1095–101.

    Article  CAS  PubMed  Google Scholar 

  107. Takeshita N, Yoshino T, Mutoh S, Yamaguchi I. Possible involvement of vitamin D3-deficiency and relatively enhanced bone resorption in the development of bone loss in streptozotocin-induced diabetic rats. Life Sci. 1994;55:291–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the Martha Ann Pugh Diabetes Research Fund (to K.M.T.), the Arkansas Biosciences Institute (to J.L.F.), and in part by a National Institutes of Health Grant R01DK055653 (to J.L.F.).

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    Kathryn M. Thrailkill & John L. Fowlkes

  2. Arkansas Children’s Hospital, 1 Children’s Way; Slot 512-6, Little Rock, AR, 72202, USA

    Kathryn M. Thrailkill

Authors
  1. Kathryn M. Thrailkill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John L. Fowlkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathryn M. Thrailkill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thrailkill, K.M., Fowlkes, J.L. The Role of Vitamin D in the Metabolic Homeostasis of Diabetic Bone. Clinic Rev Bone Miner Metab 11, 28–37 (2013). https://doi.org/10.1007/s12018-012-9127-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-012-9127-9

Keywords

Search

Navigation